On previous calls Nader had indicated we would def

Quote:

---

On previous calls Nader had indicated we would definitely need to do a Phase III for HIV monotherapy and this BLA submission would not cover that. Has this changed?

---

Since the FDA demanded the Integrated Assessment of the CD03 Mono data (under the guise of wanting the Mono safety data), I believe Dr.NP is going to ask the FDA for updated guidance regarding the approval process for Mono.

My assumption is that CytoDyn is going to explore the possibility of a Mono approval without the Phase 3 Registration trial currently slated to begin by the end of the year.